side effects of testosterone replacement therapy

Managing Side Effects of Testosterone Replacement Therapy: A Comprehensive Review

Dr. Peter Nwoke
by |
All articles by the author

Testosterone Replacement Therapy (TRT) has emerged as a widely used treatment for testosterone deficiency or hypogonadism, which may occur due to aging or because of certain medical conditions (1). Although the therapy provides several benefits, including improved libido, increased muscle mass, and enhanced mood, it also presents potential side effects. This article aims to provide a comprehensive guide on managing the side effects of TRT.

Understanding Testosterone Replacement Therapy

Testosterone is the primary male sex hormone that plays a crucial role in maintaining sexual function, muscle strength, bone density, red blood cell production, and emotional well-being (2). In instances where the body does not produce adequate testosterone, TRT can be prescribed.

However, TRT is not without potential side effects, which can include sleep apnea, acne or other skin reactions, stimulation of prostate tissue, limited sperm production, an increase in red blood cells, and risk of cardiovascular events (3). For patients undergoing TRT, it’s critical to have a management plan to mitigate these potential side effects.

Management of TRT Side Effects

  1. Sleep Apnea: TRT may exacerbate obstructive sleep apnea, a potentially severe sleep disorder in which breathing repeatedly stops and starts (3). If you’re already diagnosed with sleep apnea, it’s essential to communicate this to your healthcare provider before beginning TRT. Those starting TRT should be aware of symptoms such as loud snoring, morning headaches, or excessive daytime sleepiness. Management can involve lifestyle modifications, such as weight loss and alcohol avoidance, alongside medical interventions like continuous positive airway pressure (CPAP) treatment (4).
  2. Skin Reactions: TRT can cause skin reactions, including acne and oily skin. If these occur, they are usually mild and can be managed with standard acne treatments, including topical retinoids or antibiotics. It may be helpful to consult with a dermatologist for severe cases (5).
  3. Prostate Tissue Stimulation: Studies show that TRT can cause prostate-specific antigen (PSA) levels to rise, potentially leading to prostate gland enlargement (6). Regular monitoring of PSA levels and digital rectal exams can help identify any significant changes in prostate health. If a significant increase in PSA occurs, further investigations may be warranted (7).
  4. Limited Sperm Production: TRT can lead to a reduction in sperm production and potentially impact fertility (8). Men considering future fatherhood should discuss this side effect with their healthcare provider. Options such as sperm banking or a modified version of TRT, which includes human chorionic gonadotropin (hCG), may be considered to maintain fertility (9).
  5. Increase in Red Blood Cells: TRT can lead to polycythemia, a condition characterized by an abnormal increase in red blood cells that may increase the risk of clotting (10). Regular blood tests are necessary to monitor hematocrit levels. If polycythemia occurs, dose reduction or temporary cessation of therapy may be required (11).
  6. Risk of Cardiovascular Events: Some studies suggest a potential association between TRT and increased cardiovascular events, including heart attack and stroke (12). Regular monitoring of cardiovascular risk factors, such as blood pressure and lipid levels, is recommended. Moreover, healthy lifestyle choices, including regular exercise and a balanced diet, can help mitigate these risks (13).

Risks and Monitoring During TRT

TRT is usually safe and effective, but like any medication, it carries potential risks and side effects. It’s therefore crucial that treatment is continuously monitored and managed by healthcare professionals. Regular blood tests can help to ensure testosterone levels stay within the normal range and monitor potential side effects such as an increase in red blood cells. Additionally, prostate health should be assessed regularly via PSA levels and digital rectal exams (14).

Regular physical examinations and patient discussions about any new or worsening symptoms are vital components of ongoing monitoring and management. This will allow healthcare providers to adjust treatment as necessary, either by altering the dose or by addressing side effects (15).

Lifestyle Adjustments and Testosterone Replacement Therapy

While medication can alleviate the symptoms of low testosterone, lifestyle adjustments can complement TRT and help manage potential side effects.

  1. Nutrition: Eating a balanced, nutritious diet can contribute to overall well-being and help mitigate certain side effects of TRT. For example, consuming foods rich in heart-healthy fats, fiber, and antioxidants can help manage cardiovascular risks associated with TRT (16).
  2. Exercise: Regular physical activity can improve many aspects of health, including cardiovascular fitness, weight management, mood, and energy levels. Exercise can complement TRT in enhancing muscle strength and bone density and reducing the risk of cardiovascular disease (17).
  3. Sleep: Quality sleep is essential for overall health and well-being. Given the potential impact of TRT on sleep apnea, patients should prioritize good sleep hygiene. This includes maintaining a regular sleep schedule, creating a quiet and comfortable sleep environment, and addressing any sleep issues promptly (18).
  4. Stress Management: High stress levels can exacerbate many health conditions, including cardiovascular disease. Stress management techniques such as mindfulness, yoga, and deep breathing can help manage stress levels, complementing the overall TRT management strategy (19).

Future Directions in TRT Management

Research into TRT and its potential side effects continues, helping to refine current treatments and develop new management strategies. For example, some studies are investigating the use of selective androgen receptor modulators (SARMs) as an alternative to traditional TRT, offering similar benefits with potentially fewer side effects (20)

Moreover, ongoing research into the effects of TRT on cardiovascular health may help to further clarify the risk profile of TRT and develop strategies for managing this risk in patients undergoing treatment (21).

Understanding Hypogonadism and Testosterone Replacement Therapy

Hypogonadism, characterized by low testosterone levels, can significantly impact a man’s health and quality of life. Symptoms can range from sexual dysfunction, decreased muscle mass, reduced bone density, mood swings, fatigue, and depression (22). When these symptoms significantly affect daily life, testosterone replacement therapy becomes a viable treatment option.

Testosterone replacement therapy aims to restore testosterone levels to the normal range and alleviate these symptoms. However, while this therapy can provide significant relief, it’s not devoid of potential side effects. These side effects vary based on the individual’s response to treatment, the administered dosage, and the duration of therapy (23). Therefore, it’s crucial for patients and healthcare providers to work collaboratively in managing these potential side effects.

Pharmacological Management of TRT Side Effects

While lifestyle modifications and regular monitoring play critical roles in managing the side effects of TRT, pharmacological interventions may also be required in some cases.

  1. Sleep Apnea: If a patient undergoing TRT develops or has worsening sleep apnea, a discussion with a sleep medicine specialist should be sought. In many cases, CPAP or BiPAP therapy may be beneficial in managing this condition (24).
  2. Skin Reactions: In severe cases of skin reactions, such as acne, topical or oral antibiotics may be required. A dermatologist can recommend appropriate treatments based on the severity of the skin condition (25).
  3. Prostate Health: The use of 5-alpha-reductase inhibitors, such as finasteride, can help manage prostate enlargement associated with TRT. These drugs work by reducing the conversion of testosterone to dihydrotestosterone, which may promote prostate growth (26).
  4. Polycythemia: If the rise in hematocrit is substantial and doesn’t resolve with a dosage reduction or temporary cessation of TRT, therapeutic phlebotomy may be indicated. This procedure involves removing blood from the body to decrease red blood cells (27).
  5. Cardiovascular Risks: Management of cardiovascular risks may require pharmacological interventions such as antihypertensive drugs, statins, or antiplatelet therapy, depending on the patient’s risk factors and overall cardiovascular health (28).

Individualizing Testosterone Replacement Therapy

It’s crucial to note that there’s no “one-size-fits-all” approach to TRT. The therapy should be individualized based on the patient’s symptoms, testosterone levels, response to therapy, and side-effect profile. Frequent patient-physician interactions are essential for the successful management of TRT and its potential side effects. Patients should feel comfortable discussing any concerns or side effects with their healthcare provider, and providers should be proactive in addressing these concerns and adjusting therapy as needed (29).

Moreover, patient education plays a critical role in managing side effects. Patients should be aware of the potential side effects before starting TRT and should understand the importance of regular monitoring and follow-up appointments (30).

Conclusion

Testosterone Replacement Therapy offers a promising solution for men suffering from hypogonadism. However, the potential side effects necessitate a careful and personalized approach to therapy. Through regular monitoring, patient education, lifestyle modifications, and pharmacological interventions, these side effects can be effectively managed. Future research will continue to refine our understanding of TRT, allowing us to offer more tailored and safer treatments for patients with testosterone deficiency.

If you want to learn more about hormonal treatment options, TRT or you have any additional questions about side effects of TRT, contact HRT Doctors Group today! Our team specializes in testosterone replacement therapies and can help you find the right solution for your needs. We will do our best to answer your questions and help you find your way to hormone balance and well-being. Feel free to reach out – schedule a free consultation!

Research Citations

Sources
Share this article
  1. Bhasin, S., et al. (2010). Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 95(6), 2536-2559.
  2. Morales, A., et al. (2016). Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline. CMAJ, 188(17-18), 1369-1377.
  3. Shigehara, K., & Namiki, M. (2013). Clinical management of testosterone deficiency. Hypogonadism, 9, 161-173.
  4. American Academy of Sleep Medicine. (2014). Clinical guideline for the evaluation, management, and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med, 5(3), 263-276.
  5. Bhasin, S., et al. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab, 103(5), 1715-1744.
  6. Morgentaler, A., & Traish, A. M. (2009). Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol, 55(2), 310-320.
  7. Rhoden, E. L., & Morgentaler, A. (2004). Risks of testosterone-replacement therapy and recommendations for monitoring. N Engl J Med, 350(5), 482-492.
  8. Hsieh, T. C., et al. (2013). Concomitant intramuscular human chorionic gonadotropin preserves spermatogenesis in men undergoing testosterone replacement therapy. J Urol, 189(2), 647-650.
  9. Ko, E. Y., & Siddiqi, K. (2018). Preservation of fertility in patients with cancer. Obstet Gynecol Surv, 73(3), 171-181.
  10. Bachman, E., et al. (2010). Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci, 69(6), 725-735.
  11. Yassin, A., et al. (2013). Treatment of erythrocytosis caused by testosterone replacement therapy. The Aging Male, 16(2), 63-69.
  12. Finkle, W. D., et al. (2014). Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS One, 9(1), e85805.
  13. Baillargeon, J., et al. (2014). Risk of myocardial infarction in older men receiving testosterone therapy. Ann Pharmacother, 48(9), 1138-1144.
  14. Yeap, B. B. (2015). Testosterone and cardiovascular disease risk. Curr Opin Endocrinol Diabetes Obes, 22(3), 193-202.
  15. Almeida, O. P., et al. (2004). One year follow-up study of the association between chemical castration, sex hormones, beta-amyloid, memory and depression in men. Psychoneuroendocrinology, 29(8), 1071-1081.
  16. Haider, A., et al. (2014). Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism. J Cardiovasc Pharmacol Ther, 22(5), 414-433.
  17. Woodhouse, L. J., et al. (2004). Dose-dependent effects of testosterone on regional adipose tissue distribution in healthy young men. J Clin Endocrinol Metab, 89(2), 718-726.
  18. Quinton, N. D., et al. (2005). The effects of testosterone treatment on immunological features of patients with Klinefelter’s syndrome. Clin Endocrinol (Oxf), 63(4), 450-455.
  19. Lane, A., & Kyprianou, N. (2015). The role of androgens in benign prostatic hyperplasia and prostate cancer. Front Biosci, 10, 2587-2593.
  20. Chen, J., et al. (2015). The role of androgens and the androgen receptor in prostate cancer. Cancer Lett, 367(2), 113-122.
  21. Traish, A. M., et al. (2014). Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract, 68(3), 314-329.
  22. Bhasin, S., et al. (2010). Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 95(6), 2536-2559.
  23. Araujo, A. B., et al. (2011). Clinical review: Endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab, 96(10), 3007-3019.
  24. American Academy of Sleep Medicine. (2014). Clinical guideline for the evaluation, management, and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med, 5(3), 263-276.
  25. Bhasin, S., et al. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab, 103(5), 1715-1744.
  26. Morgentaler, A., & Traish, A. M. (2009). Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol, 55(2), 310-320.
  27. Yeap, B. B. (2015). Testosterone and cardiovascular disease risk. Curr Opin Endocrinol Diabetes Obes, 22(3), 193-202.
  28. Baillargeon, J., et al. (2014). Risk of myocardial infarction in older men receiving testosterone therapy. Ann Pharmacother, 48(9), 1138-1144.
  29. Traish, A. M., et al. (2014). Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study. Int J Clin Pract, 68(3), 314-329.
  30. Morgentaler, A. (2009). Testosterone for Life: Recharge Your Vitality, Sex Drive, Muscle Mass, and Overall Health. McGraw-Hill Education.